References
- Bentley,D.R., Balasubramanian,S., Swerdlow,H.P., Smith,G.P., Milton,J., Brown,C.G., Hall,K.P., Evers,D.J., Barnes,C.L., Bignell,H.R. et al. (2008) Accurate whole human genome sequencing using reversible terminator chemistry. Nature, 456, 53–59.
- LaFlamme, B. (2014) How we build a better tomato. Nature Gen.
- Tanner, T.J., et al. (2016) Creation of the first ultra-low gluten barley (Hordeum vulgare L.) for coeliac and gluten-intolerant populations. Plant Biotechnology 14: 1139-1150.
- Franks, S.J., et al. (2014) Evolutionary and plastic responses to climate change in terrestrial plant populations. Evol. Appl. 7: 123–139.
- Gilbert, J., et al. (2003) Rebuilding Big Pharma’s Business Model. Windhover Information Inc. Vol 21: No. 10.
- Ashburn, T.T. and Thor, K.B. (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews. Drug Discovery 3: 673-683.
- Marcotte, R., et al. (2016) Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance. Cell 164:293-309.
- Shedure, J. and Lieberman, E. (2012) The expanding scope of DNA sequencing. Nature Biotechnology 30: 1084-1094.
- Grant, G.R., et al. (2007) Analysis and management of microarray gene expression data. Current Protocols in Molecular Biology, Chapter 19: Unit 19.6.